Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

Clinical trial NCT05251727 · TERMINATED

Trial details

NCT number: NCT05251727
Sponsor: Veloxis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-induced Peripheral Neuropathy

Start date: 2022-03-24
Primary completion: 2024-06-05
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.